CDK4 and breast carcinoma: However, a very recent study based on mouse models of breast cancer and other solid tumors and on a confirmatory trascriptomic analysis of serial biopsies from a clinical trial involving CDK4/6i in breast cancer, showed that CDK4/6 inhibition might also induce a broad spectrum of immunologic events.